Brief: Elicera Therapeutics Enters Agreement With BionNTech

Elicera Therapeutics AB

09/11/2021 13:32

Nov 9 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ELICERA THERAPEUTICS ENTERS AGREEMENT WITH BIONTECH FOR
CONTRACT
MANUFACTURING OF VIRAL VECTORS FOR CAR T-CELL THERAPY
    * WE EXPECT TO HAVE COMPLETED PRODUCTION OF VIRAL VECTORS BY
SECOND HALF OF 2022 AND THAT WE CAN START TREATING PATIENTS WITH
ELC-401 BY SECOND HALF OF 2023

Source text for Eikon:  ID:nWkrPR5T0 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))